Prophylaxis News and Research

RSS

Immunological responses against monkeypox virus concerning the 2022 outbreak

A new study aimed to analyze the kinetics of the pox-specific T-cell induction, the inflammatory profile, and the inflammatory profile in human cases of the current monkeypox outbreak.

9 Nov 2022

Study suggests anti-PF4 antibodies may play a role in the severe multiorgan disease manifestations of COVID-19

Researchers investigated the association between the increased levels of anti-platelet factor 4 antibodies and the clinical complications of COVID-19.

7 Nov 2022

UC researchers receive NIH grant to study how alcohol, fentanyl affect HIV medications

The United States has set a goal of reducing the number of new HIV infections by 75% by 2025 and by at least 90% by 2030, mirroring the United Nations' initiative to end the AIDS epidemic as a global health threat by 2030.

2 Nov 2022

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the Phase 1 clinical study, recently labeled as a "national priority" by CAPNET (National Steering Committee for Therapeutic Trials and other Research on Covid-19).

28 Oct 2022

Large listeriosis outbreak in Spain caused by contaminated stuffed pork

Listeria bacteria are ubiquitous in the environment and consumption of food contaminated with Listeria monocytogenes is one of the main routes for food-borne outbreaks.

28 Oct 2022

Antibody-mediated protection against symptomatic COVID achieved at low serum neutralizing titers

In a recent study posted to the medRxiv* preprint server, researchers in the United States assessed the efficiency of protection mediated by antibodies against symptomatic coronavirus disease 2019 (COVID-19) at low serum-neutralizing titers.

24 Oct 2022

What are the predictors of new-onset diabetes in hospitalized COVID-19 patients?

Researchers evaluated the incidence and predictors of new-onset diabetes (NOD) in patients hospitalized with coronavirus disease 2019 (COVID-19).

18 Oct 2022

Recent innovations in infectious disease diagnostics

A recent Clinical Biochemistry editorial reports the latest innovations in the field of infectious disease diagnostics.

17 Oct 2022

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Researchers evaluated the changing risk of severe COVID-19 outcomes in individuals with primary and secondary immunodeficiencies in the context of COVID-19 vaccinations.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Researchers engineered biparatopic nanobodies against SARS-CoV-2.

5 Oct 2022

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Researchers described the human monkeypox virus infection after vaccination with the modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine.

5 Oct 2022

Preventive malaria treatment is a cost-effective strategy for saving young lives

Young children in sub-Saharan Africa often become severely anaemic as consequence of a malaria infection. Treating them requires blood transfusions and they must stay hospitalized for several days.

3 Oct 2022

French study reports growing evidence of sexual activity-linked transmission of monkeypox

In a new study, researchers described patients with monkeypox virus (MPXV) infection.

3 Oct 2022

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

In a new study, researchers investigated the efficacy of curcumin as a blue light photosensitizing agent for photodynamic therapy (PDT), as a prophylactic agent, and as a therapeutic agent against SARS-CoV-2.

30 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

Creating a mutation that inhibits how the bacterial pathogen Neisseria gonorrhoeae causes gonorrhea, a common sexually transmitted infection, could offer a new way to prevent and treat the disease, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

23 Sep 2022

An unusual case of Monkeypox virus transmission by needlestick injury

In a recent study published in the U.S. Centers for Disease Control and Prevention journal Emerging Infectious Diseases, researchers described an unusual case of patient-to-healthcare worker (HCW) monkeypox virus (MPXV) transmission via a needlestick injury that occured in Brazil.

21 Sep 2022

Prophylaxis News and Research

Immunological responses against monkeypox virus concerning the 2022 outbreak

Study suggests anti-PF4 antibodies may play a role in the severe multiorgan disease manifestations of COVID-19

UC researchers receive NIH grant to study how alcohol, fentanyl affect HIV medications

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

Large listeriosis outbreak in Spain caused by contaminated stuffed pork

Antibody-mediated protection against symptomatic COVID achieved at low serum neutralizing titers

What are the predictors of new-onset diabetes in hospitalized COVID-19 patients?

Recent innovations in infectious disease diagnostics

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Inhalation therapeutics against COVID-19

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Preventive malaria treatment is a cost-effective strategy for saving young lives

French study reports growing evidence of sexual activity-linked transmission of monkeypox

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

Designing a new treatment to treat migraine effectively

How smallpox and monkeypox viruses affect the nervous system

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

An unusual case of Monkeypox virus transmission by needlestick injury

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News